[Federal Register Volume 67, Number 59 (Wednesday, March 27, 2002)]
[Notices]
[Pages 14717-14718]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-7276]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-34]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda Perryman, 
CDCAssistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Ovarian Cancer Patterns of Care Study--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC). Ovarian 
cancer is the second most common gynecologic cancer in the United 
States (U.S.), with 23,100 new cases and 14,000 deaths expected in 
2001. Five-year relative survival is 95% for cases diagnosed at 
localized stage (25% of ovarian cancers), 79% for cases diagnosed with 
regional disease (9% of ovarian cancers), and 28% for those with 
distant disease at diagnosis (60% of ovarian cancers). Currently, 
screening tests that would detect ovarian cancer at an early stage and 
thus decrease mortality are not available.
    Studies suggest that some ovarian cancer patients may not receive 
recommended treatment and staging. Limited information regarding 
recent, population-based estimates of the patterns of care for ovarian 
cancer treatment is available. While cancer registries generally 
collect information on treatment and stage of disease, detailed 
information is often not reported, and the accuracy of treatment and 
stage data collected is unknown.
    The purpose of this project is to determine the type of treatment 
received by ovarian cancer patients, the medical specialty providing 
care, treatment outcome, staging procedures performed, and the accuracy 
of treatment and staging data in central cancer registries. A random 
sample of 1,500 cases per site diagnosed with first primary ovarian 
cancer is selected from three population-based central cancer 
registries (diagnosis years 1998-2000 in New York State and California, 
and 1997-2000 in Maryland). Because not all information may have been 
reported to the central cancer registries, this data will be collected 
from medical records of these cases for patient and tumor 
characteristics, treatment, and staging. Data collected will be sent to 
CDC investigators for analysis. The estimated annualized cost to 
respondents is $650,000.

----------------------------------------------------------------------------------------------------------------
                                                                          Number of      Average
                                                            Number of     responses     burden of   Total burden
                       Respondents                         respondents       per        response      (in hours)
                                                                         respondent    (in hours)
----------------------------------------------------------------------------------------------------------------
Physicians (M.D., D.O.).................................         2250             1         15/60           563
                                                         -------------------------------------------------------
      Total.............................................  ............  ............  ............          563
----------------------------------------------------------------------------------------------------------------



[[Page 14718]]

    Dated: March 18, 2002.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-7276 Filed 3-26-02; 8:45 am]
BILLING CODE 4163-18-P